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PURPOSE. To investigate the tear cytokine profile in congenital aniridia, and correlate cytokine
levels with ophthalmologic findings.
METHODS. We examined 35 patients with aniridia and 21 healthy controls. Tear fluid was
collected with Schirmer I test and capillary tubes from each eye, and the concentration of 27
inflammatory cytokines determined using multiplex bead assay. Eyes of all participants were
examined with tests for dry eye disease, including evaluation of meibomian glands
(meibography). Differences in cytokine levels between the two groups were analyzed, and
correlations between cytokine concentrations and ophthalmologic findings in the aniridia
group investigated.
RESULTS. The concentrations of six tear cytokines were significantly higher in aniridia patients
than controls in both eyes, and included interleukin 1b (IL-1b), IL-9, IL-17A; eotaxin; basic
fibroblast growth factor (bFGF/FGF2); and macrophage inflammatory protein 1a (MIP-1a/
CCL3). The ratio between the anti-inflammatory IL-1RA and the proinflammatory IL-1b was
significantly lower in patients than controls in both eyes (P ¼ 0.005 right eye and P ¼ 0.001
left eye). Increasing concentration of IL-1b, IL-9, IL-17A, FGF2, and MIP-1a correlated with
parameters for meibomian gland dysfunction (MGD) in the aniridia group, including
increasing atrophy of meibomian glands, and shorter break-up time of the tear film.
CONCLUSIONS. A number of pro-inflammatory cytokines are significantly elevated in tear fluid
from aniridia patients, and correlate with parameters for MGD in aniridia. Increased
inflammation of the ocular surface may be a factor in the development of MGD in aniridia
patients, and explain the high prevalence of MGD and dry eye disease in these patients.
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Congenital aniridia is a rare disorder that affects bothanterior and posterior parts of the eye, including the
cornea, iridocorneal angle, iris, lens, retina, and optic nerve.
The prevalence in Norway is 1:76,000.1 Hypoplasia of the iris
and of macula lutea is present in most patients and commonly
results in photophobia, considerably reduced visual acuity, and
nystagmus. Progressive ocular disorders such as glaucoma,
cataract, and aniridia-associated keratopathy (AAK) are com-
mon.1,2 Mutation in the PAX6 gene is the major genetic
explanation for aniridia.3
The prevalence of dry eye disease (DED) in aniridia is high.4
Besides, significant correlation has been found between DED
and the severity of AAK.5 As AAK is a sight-threatening
complication, investigations of DED in aniridia patients may
provide important knowledge that brings better visual out-
come.
Increased levels of various inflammatory cytokines in the
tear fluid have been demonstrated in DED.6 Moreover, elevated
concentration of these cytokines was correlated with increased
severity of DED. Inflammation can lead to ocular surface
epithelial disease and altered corneal epithelial barrier function
in DED.7 DED may thus initiate AAK through activating
inflammatory pathways. In turn, AAK might exacerbate DED
through inducing inflammatory cascades, creating a vicious
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circle. To our knowledge, this is the first published study to
comprehensively analyze inflammatory tear cytokines in
aniridia patients. By investigating the tear cytokine profile in
these patients, we aim to add clues to the pathogenesis of DED




The study comprised 35 patients (21 females) with congenital
aniridia (age range: 972 years) and 21 healthy controls (12
females; age range: 1965 years). The aniridia group was
recruited through the patient organization Aniridia Norway.
Patients had previously been diagnosed with aniridia, and the
diagnosis was confirmed by ophthalmoscopy before inclusion
in the study. Ethics committee approval was obtained from
the Norwegian Regional Committees for Medical and Health
Research Ethics (Application no. 2014/382) and the study was
conducted in accordance with the tenets of the Declaration of
Helsinki. All participants gave written consent after receiving
oral and written information about the study.
Dry Eye Examination, Sample Collection and
Storage
Results from dry eye examinations were used for correlation
analysis with cytokine concentrations. The results from dry eye
examinations were presented in a separate manuscript.
Measurement of Tear Production and Collection of
Tear Fluid
Tear meniscus height was measured with a corneal topogra-
pher (OCULUS Keratograph 5M; OCULUS, Wetzlar, Germany).
Tear fluid was collected with Schirmer I tear test using test
strips (Schirmer Tear Test Strips; Haag-Streit UK, Essex, UK),
and capillary tubes. Collection was performed without topical
anesthesia. Wearing gloves, the examiner placed the test strip
(Haag-Streit UK) at the lateral eyelid margin. The participants
had their eyes closed during the procedure, and both eyes
were tested simultaneously. The strip was removed after 5
minutes, and the wetted part measured on a millimeter scale
up to the indentation line. The strip was then stored in a
cuvette containing 500 mL phosphate buffered saline, which
was subsequently placed in a deep freezer at 808C.
Tear production was further measured with a phenol red
thread test (Tianjin JingMing New Technological Development
Co., Tianjin, China), without topical anesthesia and for 15
seconds.
Next, tear fluid was collected in capillary tubes. To obtain
contact with the tear meniscus, the tube end was placed at the
lateral lower eyelid margin, avoiding contact with the eyelid or
bulbar conjunctiva. Samples were collected from both eyes,
and the capillary tubes stored at 808C.
Measurement of Tear Film Quality and Ocular
Surface Staining
Tear film osmolarity was measured with commercial equip-
ment (TearLab; TearLab Corp., San Diego, CA, USA). Tear film
lipid layer was evaluated by recording interference images on
the keratograph during several blink intervals (lipography).
The test was designated as positive if spread of the lipid layer
could be observed, or negative if not.
Fluorescein break-up time was measured after placing 5 lL
of 2% fluorescein sodium (Minims Fluorescein Sodium 2%;
Bausch & Lomb House, Surrey, UK) into the conjunctival sac.
The time from a blink to break up of the tear film was then
measured. Without delay, punctate fluorescein vital staining of
the conjunctiva and cornea was then assessed using the Oxford
grading scheme.8
Corneal Sensitivity
Central corneal sensitivity was measured using an esthesiom-
eter (Cochet-Bonnet; Luneau Ophthalmology, Chartres,
France). The esthesiometer contained a 60-mm long monofil-
ament, which was retracted in 5-mm steps from its full length,
until a blink response was elicited.
Examination of Eyelids
Eyelid pathology was denoted as either present or absent in
each of the following eight groups: debris at the eyelid margin,
edema and thickening of the eyelid, irregularity of the lid
margin, hyperemia in the eyelid, telangiectasia in the eyelid,
occlusion of gland orifices at the lid margin, and presence of
conjunctival papillae or conjunctival hyperemia.
Expression of meibomian glands (MGs) was performed in
lower eyelid, and expressibility based on number of central five
glands that expressed secretion. Quality of expressed secretion
was graded according to recommendations from the Interna-
tional Workshop on meibomian gland dysfunction.9
MGs were visualized taking infrared images with the
keratograph. MG loss in upper and lower eyelid was evaluated
subjectively and staged according to a four-point scale
(meiboscore). The percentage area of MG loss was defined
as the area of MG loss in relation to the total visible tarsal area
and given a score from 0 to 3. A score of 0 represented an area
of MG loss of 0% to 25%; a score of 1 represented an area of
MG loss of 26% to 50%; a score of 2 represented an area of MG
loss of 51% to 75%; and score of 3 represented an area of MG
loss of >75%.
Clinical Evaluation of the Eye
Anterior part of the eye was examined with a slit-lamp
biomicroscope. AAK was graded according to a modification
of Mackman’s classification.10 Stage 0 indicated no involvement
of the cornea; stage 1 referred to ingrowth of conjunctival
tissue in the peripheral cornea from less than 3608 of the
corneoscleral limbus; stage 2 related to 3608 conjunctivaliza-
tion of the peripheral cornea, but clear central cornea; and
stage 3 described presentation as in stage 2, but included
conjunctival vascularization and/or stromal involvement of the
central cornea. Amount of iris hypoplasia was classified as
either total, if no iris tissue was visible, or partial if some tissue
could be seen. Stage of cataract was graded according to the
Lens Opacities Classification System III.11
Analyses of Tear Fluid
Cytokine concentration in the tear fluid was measured using
immunoassay technology (Bio-Plex XMap; Bio-Rad Laborato-
ries, Inc., Hercules, CA, USA) with a commercial instrument
(Luminex IS 100; Luminex Corp., Austin, TX, USA) powered by
commercial software (Bio-Plex version 6.0.1; Bio-Rad Labora-
tories, Inc.). Do modest sample volumes, the multiplex assay
was performed with half the standard sample volume, beads,
detection antibody, and streptavidin-phycoerythrin. To opti-
mize the assay for low-level detection, screening was carried
out with an additional standard point along with increased
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incubation time of beads and sample up to an hour. The broad
screening kit (Bio-Plex Pro Human Cytokine 27-plex Assay, Cat.
No. M50-0KCAF0Y; Bio-Rad Laboratories, Inc.) contained 27
different cytokines: IL-1b, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-
10, IL-12p70, IL-13, IL-15, IL-17A, IL-1RA (receptor antagonist);
eotaxin, basic fibroblast growth factor (bFGF/FGF2); granulo-
cyte colony-stimulating factor; granulocyte macrophage colo-
ny-stimulating factor; interferon gamma; interferon gamma-
induced protein 10; monocyte chemoattractant protein 1;
macrophage inflammatory protein 1b (MIP-1a/CCL3); MIP-1b ;
platelet-derived growth factor bb; regulated-on-activation
normal T cell expressed and secreted; tumor necrosis factor
alpha; and vascular endothelial growth factor.
Not all participants completed the Schirmer and capillary
test, and from some of them no visible tear fluid was collected
in the capillary tubes. To ensure sufficient tear fluid for
analyses, 11 Schirmer tests with 5-mm wetting or less were
discarded (five from aniridia group and six from control
group). All tear samples were thawed on ice and 6 lL of tear
fluid from capillary tubes were mixed with 24 lL of sample
diluent and added to the test plate. In a small number of cases
in which tear fluid volume was less than 6 lL, sample diluent
was added to final volume of 30 lL, and the diluent factor
adjusted accordingly. The cuvettes with Schirmer strips
stored in phosphate buffered saline were vortexed, and 25
lL of the suspension was added directly to the plate.
Individual sets of samples from patients were run on the
same plate. Plates were washed with a magnetic plate washer
(Bio-Plex Pro Wash Station; Bio-Rad Laboratories, Inc.). The
standard curve for each cytokine was performed in duplicate
using recombinant proteins in a 4-fold dilution. Results were
validated by a five-parametric logistic curve modeling and
used to determine the protein levels in the tear fluid samples.
Longitudinal controls were applied to obtain inter- and
intrapercent coefficient of variation. All values were in
acceptable range according to recommendations from the
manufacturer (intrapercent coefficient of variation <11 and
interpercent coefficient of variation >21). Protein concentra-
tions in the Schirmer strip suspensions were adjusted as a
direct function of the total length of wetted strip, which was
calculated from the Schirmer test result.
Quantitative and Statistical Analyses
Statistical analyses were performed with statistical software
(SPSS software version 23.0; IBM Corp., Armonk, NY, USA).
Cytokine levels were calculated in four groups: Schirmer test
right eye (SOD) and left eye (SOS), and capillary test right eye
(COD) and left eye (COS). Reported results are presented as
means 6 standard deviation. Normal distribution was analyzed
using Shapiro-Wilk test and histogram analysis, and Mann-
Whitney U test applied to calculate differences in cytokine
levels between aniridia and control subjects. The alpha level
was set to 0.05 and significant results determined by the Holm-
Bonferroni method to correct for multiple comparisons.
Correlation analyses between cytokine levels and clinical
parameters in the aniridia group were performed using
Spearman’s rank correlation and values of P  0.05 considered
as significant.
RESULTS
Mean age in the aniridia group was 34.9 6 18.7 (range: 972)
years and 31.2 6 13.9 (range: 1965) years in the control
group. Table 1 shows number of tests and mean age of
participants in the four subgroups combining Schirmer/
capillary test and right/left eye. In aniridia patients, mean
Schirmer test result was 27.5 6 9.4 mm in right eye and 27.7
6 9.1 mm in left eye.
Comparison of Cytokine Levels Between Aniridia
and Control Groups
In the SOD group, the concentrations of five cytokines were
significantly higher in aniridia patients than control subjects; in
the COD group, the levels of six cytokines were significantly
elevated in aniridia group (Table 2); in the SOS group, 17
cytokines had increased concentration in aniridia subjects; and
in the COS group, the levels of two cytokines were higher in
aniridia than controls (Table 3). None of the cytokines tested
had significantly lower concentrations in the aniridia group
than in the control group.
The concentrations were significantly higher for seven
cytokines in the right eye and 17 in the left eye in either one or
both test modalities. Consequently, a lower number of tear
cytokines had increased concentrations in the right versus the
left eye, but all the cytokines with elevated concentrations in
right eye were also raised in left eye, except for IL-2. Significant
elevation was further shown for 6 cytokines in both right and
left eye of aniridia patients compared with controls. These six
were: IL-1b, IL-9, IL-17A, eotaxin, FGF2, and MIP-1a. No
significant differences were found between right and left eye
within the aniridia and patient group.
The level of IL-1RA was lower in aniridia in all test groups,
but the differences were not statistically significant. However,
the ratio between IL-1RA and IL-1b was significantly lower in
the aniridia group in both eyes and with both Schirmer and
capillary test: in SOD 17,086 6 24,555 in aniridia versus
163,852 6 308,989 in controls (P ¼ 0.005); in SOS 8890 6
20,092 versus 104,790 6 127,283 (P¼ 0.001); and in COS 749
6 1611 versus 2238 6 3085 (P¼ 0.03). The difference in the
IL-1RA/IL-1b ratio was not significant in COD (971 6 1297
versus 4902 6 5707, P ¼ 0.07).











Schirmer OD 27 19 36.2 29.4
Schirmer OS 26 17 35.7 29.2
Capillary OD 22 18 37.9 30.4
Capillary OS 19 13 36.3 32.2
* Mean.
TABLE 2. Tear Cytokines in Right Eye With Significantly Different
Concentrations in Aniridia and Control Group
Cytokine Aniridia Control P Value*
IL-1b Schirmer test (S) 10.3 6 17.2 1.8 6 5.4 0.0001
IL-1b capillary test (C) 13.3 6 8.7 4.3 6 3.3 0.00003
IL-2 (C) 15.9 6 13.7 4.1 6 5.9 0.002
IL-9 (S) 6.5 6 5.0 2.3 6 3.8 0.001
IL-9 (C) 35.3 6 19.3 16.8 6 12.7 0.001
IL-17A (S) 20.7 6 27.0 5.5 6 21.1 0.0004
IL-17A (C) 105.8 6 111.9 2.4 610.2 0.00003
Eotaxin (C) 88.9 6 47.7 52.5 6 27.2 0.002
FGF2 (S) 65 6 54.4 19.4 6 74.5 0.0002
FGF2 (C) 189.3 6 150.6 10.3 6 43.9 0.00003
MIP-1a (S) 1.8 6 1.4 0.7 6 1.7 0.001
MIP-1a (C) 13.0 6 6.4 7.1 6 4.7 0.001
Mean 6 SD; cytokines (pg/mL).
* Mann-Whitney U test and Holm-Bonferroni method.
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Correlation Between Cytokine Levels and DED
Findings in Aniridia Group
The five cytokines that were significantly elevated in both eyes
and with both Schirmer and capillary test in at least one eye,
were included in correlation analyses. These five cytokines
were: IL-1b, IL-9, IL-17A, FGF2, and MIP-1a. Correlations were
calculated between cytokine levels and clinical findings in the
aniridia group (Fig.; Table 4).
Considering the relationship between tear production and
cytokine concentrations, positive correlations were found
between Schirmer test results in right eye and cytokines
extracted from SOD for all five cytokines in the analysis (IL-1b:
r ¼ 0.622, P ¼ 0.001; IL-9: r ¼ 0.519, P ¼ 0.006; IL-17A: r ¼
0.382, P¼ 0.049; FGF2: r¼ 0.423, P¼ 0.03; MIP-1a: r¼ 0.588,
P ¼ 0.001). Hence, increased Schirmer values correlated with
raised cytokine levels. On the other hand, tear meniscus height
correlated negatively with MIP-1a in the left eye (SOS; r ¼
0.450, P ¼ 0.02).
Negative correlations were found between fluorescein
break-up time and the concentration of IL-17A (r ¼0.457, P
¼ 0.03) and FGF2 (r¼0.598, P¼ 0.003) in SOD, and between
positive lipography and the level of IL-9 (r¼0.400, P¼ 0.04)
and IL17-A (r ¼0.423, P ¼ 0.03) in SOS. Thus, longer tear
break-up time, and visualization of the tear film by lipography
were associated with lower concentrations of tear cytokines.
Positive correlations were observed between meiboscore in
lower eyelid and all five cytokines in the analysis (for IL-1b, IL-
9, IL-17A, and FGF2 in more than one group; for MIP-1a in
COD). Loss of meibomian glands was therefore related to
increasing levels of cytokines. Conjunctival alterations, in
terms of hyperemia and papillae, were connected to elevated
concentrations of IL-17A and FGF2 in SOS.
Correlation Between Cytokine Levels and Other
Clinical Findings
The level of IL-17A correlated negatively with corneal
esthesiometry values (r ¼ 0.441, P ¼ 0.03) in SOD (i.e.,
increased level of IL-17A was associated with lower corneal
sensitivity). Presence of total iris hypoplasia correlated
positively with IL-1b in COS (r ¼ 0.477, P ¼ 0.045).
DISCUSSION
Our results demonstrate significantly higher concentrations of
a number of inflammatory cytokines in tear fluid from aniridia
patients than in healthy controls. Additionally, the level of
certain cytokines correlates with clinical parameters common-
ly used in diagnostics of DED, including tests for MGD. The
concentrations of 18 cytokines were significantly higher in
aniridia than controls in at least one test subgroup (SOD, COD,
SOS, and COS). None of the cytokines tested had significantly
lower concentrations in the aniridia group. However, the ratio
between the anti-inflammatory IL-1RA and the pro-inflamma-
tory IL-1b was significantly higher in controls. The levels of six
cytokines were significantly elevated in both eyes in aniridia
(IL-1b, IL-9, IL-17A, eotaxin, FGF2, and MIP-1a). Bilateral
confirmation of these six cytokines makes it reasonable to
consider them as particularly important among the tested
proteins.
Several studies have successfully used multiplex bead
analysis in examination of tear fluid.12–14 Smaller sample
volumes are needed with this method than traditional
procedure—ELISA—thus both eyes could be tested separately
without need to pool samples.13 Furthermore, multiplex
analysis has good correlation with ELISA test, rapid processing
and high throughput, which allows quantification of multiple
protein targets.13
A different number of cytokines with significantly higher
concentrations was detected with Schirmer test and capillary
test from the same eye, and in the right and left eyes. This
might reflect variability in expression and severity of disease
between the two eyes in a patient with aniridia, and the ability
to detect these differences by Schirmer and capillary test. On
the other hand, the Schirmer strip was always first inserted
into right inferior fornix, and the capillary test started with
right eye, which could have influenced the results. Moreover,
the number of samples achieved was higher with Schirmer test
than with capillary test, and higher in right eye than left eye.
Cytokine levels in the Schirmer test groups correlated better
with clinical parameters than those from capillary test groups.
Our study therefore indicates that Schirmer test from one eye
should be chosen when collecting tear samples for cytokine
analyses. Exclusion of Schirmer tests with 5 mm wetting or less
may have impacted our results by excluding participants with
more severe DED.
Several cytokines have been identified in tear fluid from
normal individuals.15 Both proinflammatory and anti-inflam-
matory cytokines are present in normal eyes without
inflammation,16 and some of these are suggested to participate
in the host defense system at the ocular surface.15 Elevated
concentration of tear fluid cytokines has been shown in
patients harboring systemic diseases which affect the ocular
surface, such as graft-versus-host-disease,17 and in inflammato-
ry eye diseases involving the ocular surface.18
Increased level of many inflammatory cytokines has been
evident in patients with DED.6,12 The prevalence of DED in the
aniridia is high,4,5 and correlates with severity of AAK.5 AAK
could lead to corneal ulceration and inflammation,19 and be a
sight threatening complication in aniridia.
Elevated concentrations of IL-1b have been found in tear
fluid from DED patients,6,14 and recognized as the earliest
change in patients with DED.14 In our study, higher concen-
tration of IL1-b was associated with lower age in the aniridia
group. This may reflect that increased level of IL1-b is an initial
TABLE 3. Tear Cytokines in Left Eye With Significantly Different
Concentrations in Aniridia and Control Group
Cytokine* Aniridia Control P Value†
IL-1b (S) 20.3 6 32.8 0.7 6 1.6 0.000004
IL-4 (S) 1.7 6 1.7 0.5 6 0.3 0.0002
IL-6 (S) 6.5 6 6.6 1.7 6 1.8 0.001
IL-8 (S) 109.0 6 180.7 36.2 6 63.4 0.002
IL-9 (S) 6.8 6 6.12 0.7 6 1.0 0.000008
IL-10 (S) 14.2 6 6.7 8.1 6 5.4 0.003
IL-12 p70 (S) 30.9 6 17.7 11.9 6 11.7 0.0003
IL-13 (S) 15.0 6 12.2 5.7 6 6.0 0.002
IL-17A (S) 18.6 6 23.5 0.6 6 2.6 0.00007
IL-17A (C) 93.5 6 103.9 1.5 6 5.3 0.001
Eotaxin (S) 15.5 6 13.4 4.9 6 5.4 0.001
FGF2 (S) 56.8 6 45.7 2.1 6 8.6 0.00005
FGF2 (C) 163.7 6 147.7 10.7 6 38.6 0.001
G-CSF (S) 40.0 6 30.9 18.6 6 13.6 0.002
IFN-c (S) 44.8 6 43.9 16.9 6 12.6 0.002
MCP-1 (S) 58.1 6 85.7 26.3 6 38.0 0.003
MIP-1a (S) 2.0 6 1.9 0.0 6 0.2 0.000002
MIP-1b (S) 13.2 6 24.6 3.2 6 4.7 0.002
PDGF-BB (S) 18.9 6 13.5 4.6 6 4.8 0.00001
G-CSF, granulocyte colony-stimulating factor; MCP, monocyte
chemoattractant protein; PDGF, platelet-derived growth factor.
* Mean 6 SD; Cytokines (pg/mL).
† Mann-Whitney U test and Holm-Bonferroni method.
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finding in DED in aniridia. It is further suggested that IL-17A
plays a role in the pathogenesis of DED.20 The level of IL-17A in
tears and its expression in conjunctiva also correlated well
with parameters for DED. IL-1b and IL-17A were significantly
increased in both eyes in our study. Additionally, significant
correlations were found between the level of several cytokines
and parameters for DED, including tests for MGD. Interestingly,
increasing Schirmer test values corresponded with higher
concentration of a number of cytokines. This might reflect
increased tear production as a marker for enhanced inflamma-
tion at the ocular surface in aniridia patients. Raised tear
production is probably also a compensatory mechanism in
MGD.21
In a study by Enriquez-de-Salamanca et al.,22 increased levels
of inflammatory cytokines were found in patients with
moderate forms of evaporative DED due to MGD. Moreover,
correlations were demonstrated between cytokines and
clinical parameters for DED. In aniridia, MGD has been
identified as a possible factor in the development of DED in
most patients.5 It is likely that MGD contributes to the tear
cytokine profile demonstrated in aniridia patients. In our study,
this argument is supported by moderate to strong correlations
between elevated cytokine concentrations and increased
atrophy of MGs in terms of meiboscore. Furthermore, positive
lipography, indicating maintained tear film lipid layer, was
associated with decreased level of IL-9 and IL-17A. Longer
break-up time of the tear film, implying better function of the
tear lipid layer, was associated with lower concentration of IL-
17A and FGF2 and hence less inflammation. Additionally, the
presence of eyelid and conjunctival pathologies correlated
positively with the level of cytokines in certain subgroups.
Eyelid changes could potentially contribute to the develop-
ment of MGD, or possibly be a consequence of the disease.23
Clinically, corneal ulceration and inflammation are frequent-
ly observed in aniridia patients,19 and the presence of
inflammatory cells in the corneal limbal region was demon-
strated by laser scanning in vivo confocal microscopy.24
Confocal microscopy also showed inflammatory cells in the
central cornea despite transparency by slit-lamp examina-
tion.25 Thus, it is likely that corneal processes contribute to
inflammation at the ocular surface and increase the concen-
tration of inflammatory substances in the tear film. Correlation
between stage of AAK and cytokine level was not shown in our
study, possibly because the number of participants was not
large enough for subgroup analysis. In future studies, cytokine
levels should be analyzed in each group of AAK if enough
patients exist.
Proinflammatory properties characterize all six cytokines
that were significantly elevated in both eyes (IL-1b, IL-9, IL-17A,
eotaxin, FGF2, and MIP-1a). The expression of IL-1b is
increased in the tissue covering cornea (pannus) in limbal
stem cell deficiency.26 Furthermore, highly elevated expression
of IL-9 has been found in conjunctival cells of patients with
DED connected to graft versus host disease.27 Th17 cells
mediate ocular surface autoimmunity through IL-17A.28 Eotax-
in secreted in tears is important in the pathogenesis of seasonal
allergic conjunctivitis.29 Moreover, increased expression of
eotaxin was shown in tears and conjunctival epithelial cells of
patients with vernal keratoconjunctivitis.30 Upregulation of
FGF2 in tear fluid has been found in cases of chronic Stevens-
Johnson syndrome.31 Furthermore, an elevated level of MIP-
1a/CCL3 was demonstrated together with increasing degree of
TABLE 4. Correlation Analysis Between Levels of Five Selected Tear Cytokines and Clinical Parameters in the Aniridia Group
Clinical Parameter Test Group Cytokine Correlation Coefficient* P Value*
Age SOD IL-1b 0.485 0.01
Tear production
Tear meniscus height SOS MIP-1a 0.450 0.02
Schirmer test SOD/SOS IL-1b 0.622/0.618 0.001/0.001
SOD IL-9 0.519 0.006
SOD IL-17A 0.382 0.049
SOD FGF2 0.423 0.03
SOD MIP-1a 0.588 0.001
Phenol red test SOS FGF2 0.821 0.02
Tear film quality
Break-up time SOD IL-17A 0.457 0.03
SOD FGF2 0.598 0.003
Lipography (positive) SOS IL-9 0.400 0.04
SOS IL-17A 0.423 0.03
Eyelid
Telangiectasia eyelid SOS FGF2 0.522 0.006
Meiboscore SOD/COD IL-1b 0.488/0.477 0.04/0.04
Lower eyelid SOD/SOS IL-9 0.488/0.516 0.02/0.01
SOD/COD/SOS IL-17A 0.470/0.457/0.460 0.03/0.049/0.03
COD/SOS FGF2 0.464/0.452 0.04/0.04
COD MIP-1a 0.477 0.04
Conjunctiva
Conjunctival hyperemia COD IL-1b 0.427 0.047
SOS IL-17A 0.418 0.03
Conjunctival papillae SOS IL-17A 0.407 0.04
SOS FGF2 0.529 0.005
Cornea
Corneal sensitivity SOD IL-17A 0.441 0.03
Iris
Iris hypoplasia COS IL-1b 0.477 0.045
* Spearman’s rank correlation.
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FIGURE. Scatter plot of correlation between clinical parameters and concentration of various inflammatory tear cytokines collected with Schirmer
test in right eye: (A) correlation between Schirmer test results (mm) and concentration of IL-1b (pg/mL); (B) between Schirmer test results and MIP-
1a; (C) tear film break-up time (s) and FGF2; (D) tear film break-up time and IL-17A; (E) meiboscore and IL-9; (F) meiboscore and IL-1b. R and P
values calculated with Spearman’s rank correlation.
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neutrophilic cells in a corneal model.32 MIP-1a/CCL3 repre-
sents an important signal for mast cell degranulation in the
conjunctiva and hence for acute-phase disease.33
The proinflammatory IL-1b is an agonist and the anti-
inflammatory IL-1RA an antagonist to the same receptors, and
the balance between IL1 and IL-1RA impacts the development
of inflammatory diseases.34 In our study, the ratio between IL-
1RA and IL-1b was significantly reduced in aniridia. This
finding indicates an imbalance between pro- and anti-inflam-
matory cytokines in aniridia patients, and suggests that a
restoration of this cytokine balance (which exists in tears from
healthy subjects) could be a future therapeutic goal.
Research points to inflammatory events at the ocular
surface as a core mechanism in the development of DED.7,35
AAK probably enhances these events and serves as a possible
trigger for DED in aniridia patients. Moreover, DED potentially
leads to ocular surface epithelial disease and altered corneal
epithelial barrier function.7 Accordingly, AAK and DED may
interact, progressively breaking down the normal corneal
anatomy and reducing the patient’s vision.
In conclusion, our study demonstrates significantly higher
levels of a number of inflammatory cytokines in tear fluid from
aniridia patients than in control individuals. Moderate correla-
tions were found between cytokine concentrations and
parameters for DED, especially MGD. Increased inflammation
of the ocular surface may in part explain the high prevalence of
DED in aniridia. In turn, MGD and hence DED possibly
contribute to elevated cytokine levels in the tear fluid. As
inflammation may lead to deterioration of AAK and conse-
quently the patient’s vision, attention should be directed
toward possible treatment options targeting these disease
pathways.
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